An Integrated In Vitro and In Vivo High-Throughput Screen Identifies Treatment Leads for Ependymoma-Reference-Cited by-同舟云学术

An Integrated In Vitro and In Vivo High-Throughput Screen Identifies Treatment Leads for Ependymoma

Published:2011-09 Issue:3 Volume:20 Page:384-399
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Atkinson Jennifer M.,Shelat Anang A.,Carcaboso Angel Montero,Kranenburg Tanya A.,Arnold Leggy A.,Boulos Nidal,Wright Karen,Johnson Robert A.,Poppleton Helen,Mohankumar Kumarasamypet M.,Féau Clementine,Phoenix Timothy,Gibson Paul,Zhu Liqin,Tong Yiai,Eden Chris,Ellison David W.,Priebe Waldemar,Koul Dimpy,Yung W. K. Alfred,Gajjar Amar,Stewart Clinton F.,Guy R. Kiplin,Gilbertson Richard J.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference58 articles.

1. The proteasome: a suitable antineoplastic target;Adams;Nat. Rev. Cancer,2004

2. Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal;Aguirre;Nature,2010

3. Validated liquid chromatographic determination of 5-fluorouracil in human plasma;Alsarra;J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.,2004

4. Neuroblast protuberances in the subventricular zone of the regenerative MRL/MpJ mouse;Baker;J. Comp. Neurol.,2006

5. Effect of screening and adjuvant therapy on mortality from breast cancer;Berry;N. Engl. J. Med.,2005

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural language processing charts transcriptome evolution to design combination cancer therapies;2024-04-09

2. Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma;Clinical Cancer Research;2024-02-09

3. 6-Aryl-4-cycloamino-1,3,5-triazine-2-amines: synthesis, antileukemic activity, and 3D-QSAR modelling;RSC Advances;2024

4. Natural Language Processing Charts Transcriptome Evolution to Design Combination Cancer Therapies;2024

5. Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments;Investigative Opthalmology & Visual Science;2023-12-20